ATRC-101,Pembrolizumab
Atreca,merck
['solid tumor']
atreca presents data from ongoing phase 1b study of atrc-101 in patients with select advanced solid tumors during oral abstract session at the asco 2023 annual meeting #stocksoftheday #stockalert #stocknews #cancer #event #newclinicaltrialdata #phase1 
Find the most important news and press releases about U.S. publicly-traded companies in real-time and stay ahead of the game!